Showing results (2271-2280 of 3,030) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|January 3, 2012
Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren's syndrome: at the interplay between chronic inflammation, autoimmunity and lymphomagenesisMichele Bombardieri, Costantino PitzalisCurrent Pharmaceutical Biotechnology|January 3, 2012
Current and future challenges in primary Sjögren's syndromeArjan Vissink, Hendrika Bootsma, Fred K L Spijkervet, et al.Current Pharmaceutical Biotechnology|February 17, 2012
Functional imaging to understand biomechanics: a critical tool for the study of biology, pathology and the development of pharmacological solutionsR Aidan Jamison, James A Armitage, Josie Carberry, et al.Current Pharmaceutical Biotechnology|February 17, 2012
Ultrasound: medical imaging and beyond (an invited review)Haim AzhariCurrent Pharmaceutical Biotechnology|January 28, 2012
How drugs influencing central blood pressure prevent atherosclerosis complications?Piotr Jankowski, Michel E Safar, Kalina Kawecka-JaszczCurrent Pharmaceutical Biotechnology|January 28, 2012
Diastolic heart failure and LV dyssynchronyMario Kasner, Dirk Westermann, Heinz-Peter Schultheiss, et al.Current Pharmaceutical Biotechnology|January 31, 2012
The glutamate hypothesis of schizophrenia: neuroimaging and drug developmentAlice Egerton, James M StoneCurrent Pharmaceutical Biotechnology|January 31, 2012
Current progress in the genetic research of schizophrenia: relevance for drug discovery?Dan Rujescu, Just Genius, Jens Benninghoff, et al.Current Pharmaceutical Biotechnology|January 31, 2012
Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophreniaH Y Meltzer, B W Massey, M HoriguchiCurrent Pharmaceutical Biotechnology|January 31, 2012
Disturbed function of GABAergic interneurons in schizophrenia: relevance for medical treatment?J Genius, I Giegling, J Benninghoff, et al.Pageof 303